Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 11(1843), p. 2563-2582, 2014

DOI: 10.1016/j.bbamcr.2014.05.014

Links

Tools

Export citation

Search in Google Scholar

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

Journal article published in 2014 by Mark D. Turner ORCID, Belinda Nedjai ORCID, Tara Hurst ORCID, Daniel J. Pennington
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Inflammation occurs as a result of exposure of tissues and organs to harmful stimuli such as microbial pathogens, irritants, or toxic cellular components. The primary physical manifestations of inflammation are redness, swelling, heat, pain, and loss of function to the affected area. These processes involve the major cells of the immune system, including monocytes, macrophages, neutrophils, basophils, dendritic cells, mast cells, T-cells, and B-cells. However, examination of a range of inflammatory lesions demonstrates the presence of specific leukocytes in any given lesion. That is, the inflammatory process is regulated in such a way as to ensure that the appropriate leukocytes are recruited. These events are in turn controlled by a host of extracellular molecular regulators, including members of the cytokine and chemokine families that mediate both immune cell recruitment and complex intracellular signalling control mechanisms that characterise inflammation. This review will focus on the role of the main cytokines, chemokines, and their receptors in in the pathophysiology of auto-inflammatory disorders, pro-inflammatory disorders, and neurological disorders involving inflammation.